In This Week’s Issue:
 
1. WEBINAR TOMORROW: Public Comment on PCORI Proposed National Priorities for Health, see details below.
2. TOMORROW: AUCD Webinar on Strategies for COVID-19 Vaccine Access and Confidence for People with Disabilities, click here to register.
3. PIPC Submits Comments to CMS on National Coverage Decision for Screening Lung Cancer with LDCT, click here to read the letter.
4. Health Affairs: Medicare Beneficiaries with Disabilities More Likely to Have Preventable Emergency Room Visits, click here to view the paper.
5. RECORDING AVAILABLE -- Discrimination and Health Care: How it Impacts You, click here to view the webinar.
6. New CDC Guidance on COVID-19 Vaccines for People with Underlying Medical Conditions, click here to read more.
7. States Rely on Template Legislation that References ICER and Discriminatory Metrics, see details below.
8. Emerging Threats in States for Use of Discriminatory Metrics, see details below.
9. IVI to Hold Second Methods Summit, click here to learn more.
10. International News: What Happens in Countries Using QALYs and Cost-Based Thresholds to Determine Coverage? See below for more.
11. ICER's QALY-Based Study Topics: Hypertrophic Cardiomyopathy, Myasthenia Gravis, Atopic Dermatitis, Lupus Nephritis, Alzheimer's Disease, Asthma, click here to provide patient input.
12. Upcoming Events and Webinars, see details below.
13. Medical Journal Articles, see details below.
14. AHRQ Effective Program Updates, see details below.  

In This Week's Issue:

1. PIPC Submits Comments to CMS on National Coverage Decision for Screening Lung Cancer with LDCT, click here to read the letter.
2. HAPPENING TODAY: SIDM Webinar on Proposed Common Format for Diagnostic Errors, see details below.
3. RECORDING AVAILALE -- Discrimination and Health Care: How it Impacts You, click here to view the webinar.
4. PIPC Submits Comment Letter to ICER on Draft Evidence Report for Atopic Dermatitis, click here to read the letter.
5. New CDC Guidance on COVID-19 Vaccines for People with Underlying Medical Conditions, click here to read more.
6. Transcript Available: May 24-25 PCORI Board of Governors Meeting, click here to view.
7. SECOND WEBINAR THIS IVI Webinar Series: Toward Equity in Value Assessment, click here to learn more.
8. States Rely on Template Legislation that References ICER and Discriminatory Metrics, see details below.
9. Emerging Threats in States for Use of Discriminatory Metrics, see details below.
10. IVI to Hold Second Methods Summit, click here to learn more.
11. International News: What Happens in Countries Using QALYs and Cost-Based Thresholds to Determine Coverage? See below for more.
12. ICER's QALY-Based Study Topics: Hypertrophic Cardiomyopathy, Myasthenia Gravis, Atopic Dermatitis, Lupus Nephritis, Alzheimer's Disease, Asthma, click here to provide patient input.
13. Upcoming Events and Webinars, see details below.
14. Medical Journal Articles, see details below.
15. AHRQ Effective Program Updates, see details below.  

In This Week’s Issue:
 
1. PIPC Submits Comment Letter to ICER on Draft Evidence Report for Atopic Dermatitis, click here to read the letter.
2. PIPC Submits Comments to ICER on Draft Evidence Report for Alzheimer's Treatments, click here to read the letter.
3. IVI Webinar Series: Toward Equity in Value Assessment, click here to learn more.
4. States Rely on Template Legislation that References ICER and Discriminatory Metrics, see details below.
5. Emerging Threats in States like MD, CO, and OR for Use of Discriminatory Metrics, see details below.
6. IVI to Hold Second Methods Summit, click here to learn more.
7. Vaccination Equity and Communication, see details below.
8. International News: What Happens in Countries Using QALYs and Cost-Based Thresholds to Determine Coverage? See below for more.
9. ICER's QALY-Based Study Topics: Hypertrophic Cardiomyopathy, Myasthenia Gravis, Atopic Dermatitis, Lupus Nephritis, Alzheimer's Disease, Asthma, click here to provide patient input.
10. Upcoming Events and Webinars, see details below.
11. Medical Journal Articles, see details below.
12. AHRQ Effective Program Updates, see details below.  

In This Week’s Issue:

1. Discrimination and Health Care: How it Impacts You, click here to register for the webinar.
2. PIPC Submits Comments to ICER on Draft Evidence Report for Alzheimer's Treatments, click here to read the letter.
3. New York Times Story on the Experience of One Patient with Sickle Cell Disease, click here to read the article.
4. National Health Council and Tufts Launch New Patient-Centered Value Assessment Initiative, click here to learn more.
5. States Rely on Template Legislation that References ICER and Discriminatory Metrics, see details below.
6. Emerging Threats in States like CO and OR for Use of Discriminatory Metrics, see details below.
7. IVI to Hold Second Methods Summit, click here to learn more.
8. Vaccination Equity and Communication, see details below.
9. International News: What Happens in Countries Using QALYs and Cost-Based Thresholds to Determine Coverage? See below for more.
10. ICER's QALY-Based Study Topics: Hypertrophic Cardiomyopathy, Myasthenia Gravis, Atopic Dermatitis, Lupus Nephritis, Alzheimer's Disease, Asthma, click here to provide patient input.
11. Upcoming Events and Webinars, see details below.
12. Medical Journal Articles, see details below.
13. AHRQ Effective Program Updates, see details below.  

In This Week’s Issue:
 
1. Discrimination and Health Care: How it Impacts You, click here to register for the webinar.
2. COMMENTS DUE TOMORROW: Amplifying the Voices of Alzheimer’s, see details below.
3. New York Times Story on the Experience of One Patient with Sickle Cell Disease, click here to read the article.
4. PIPC Chairman Applauds NCD Efforts to Combat Discriminatory Health Care Policies, click here to read the letter.
5. National Health Council and Tufts Launch New Patient-Centered Value Assessment Initiative, click here to learn more.
6. States Rely on Template Legislation that References ICER and Discriminatory Metrics, see details below.
7. Emerging Threats in States like CO and ME for Use of Discriminatory Metrics, see details below.
8. IVI to Hold Second Methods Summit, click here to learn more.
9. Vaccination Equity and Communication, see details below.
10. International News: What Happens in Countries Using QALYs and Cost-Based Thresholds to Determine Coverage? See below for more.
11. ICER's QALY-Based Study Topics: Hypertrophic Cardiomyopathy, Myasthenia Gravis, Atopic Dermatitis, Lupus Nephritis, Alzheimer's Disease, Asthma, click here to provide patient input.
12. Upcoming Events and Webinars, see details below.
13. Medical Journal Articles, see details below.
14. AHRQ Effective Program Updates, see details below.